Multivessel Disease and Severe Carotid Stenosis: How to Proceed

Myocardial revascularization surgery (CABG) is the most frequent of all cardiovascular surgeries and is still the gold standard to treat multivessel disease.  Between 6 and 8% of these patients present concomitant carotid stenosis and it is associated with increased peri and post procedural stroke rates during and after surgery.

Lesión de múltiples vasos y enfermedad carotidea severa ¿Cómo proceder?

To prevent carotid stenosis, either PCI or endarterectomy can be carried out, prior CABG or simultaneously.


Read also: End of Discussion on the Impact of Pacemaker After TAVR?”


All data come from case series with different inclusion criteria or end point definitions, which is why no definite evidence from randomized and controlled studies show any advantage of endarterectomy over CABG, neither simultaneous nor staged, vs. isolated CABG.

 

Patients with severe asymptomatic stenosis to the internal carotid – ≥80% according to ECST (European Carotid Surgery Trial), or ≥70% by ECG, according to NASCET (North American Symptomatic Carotid Endarterectomy Trial)- requiring CABG were randomized to synchronous endarterectomy + CABG vs. isolated CABG. Randomization was stratified by center, age, sex and modified Rankin scale. Primary end point was rate of stroke and death at 30 days.

 

Between 2010 and 2014 a total 129 patients in 17 centers of Germany and the Czech Republic were enrolled. Poor recruitment and funding terminated enrolment earlier.


Read also: With Absorb Out, New Resorbable Scaffolds Have Come onto the Market”.


At 30 days, the rate of any stroke or death was 12/65 (18.5%) in those receiving synchronous endarterectomy + CABG compared to 6/62 (9.7%) in patients undergoing isolated CABG (absolute risk reduction 8.8%; p=0.12).

 

Secondary end points saw no significant difference between the groups both at 30 days and a year, even though there was a tendency in favor of isolated CABG.

 

Conclusion

These outcomes are not definite, due to the study’s low statistical power, but combining endarterectomy and CABG in the same procedure seems unlikely to be the best treatment strategy. The 5 year follow up is still ongoing. 

 

Editorial Comment

Carotid stenting is an alternative to endarterectomy, though most studies have shown higher periprocedural stroke rate with stenting (mostly minor stroke). This happens mostly in elderly men, who typically present with both concomitant problems. 

 

A systematic version of cohort studies has showed a stroke and death rate of 9.1% with PCI and staged CABG. Some observational studies have also favored this strategy even more.  The problem is the need of at least one month of dual antiaggregation, which postpones surgery and exposes patients to coronary events while they wait.

 

Another possible strategy is to perform PCI and, if there were no complications, take patients straight to surgery, right after the cath lab. The procedure has to be carried out without dual antiaggregation, and after surgery, if there is no bleeding, the patient can receive clopidogrel by nasogastric tube. There is no randomized evidence for this last recommendation.

 

Original title: Safety of Simultaneous Coronary Artery Bypass Grafting and Carotid Endarterectomy Versus Isolated Coronary Artery Bypass Grafting. A Randomized Clinical Trial.

Reference: Christian Weimar et al. Stroke. 2017 Oct;48(10):2769-2775.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

We are interested in your opinion. Please, leave your comments, thoughts, questions, etc., below. They will be most welcome.

More articles by this author

TCT 2024 | SIRONA: Randomized Study Comparing Sirolimus-Coated vs Paclitaxel-Coated Balloon Angioplasty in Femoropopliteal Disease

This prospective, randomized, multicenter, investigator-initiated non-inferiority study compared the use of sirolimus-coated balloon (MagicTouch) vs paclitaxel-coated balloon in endovascular treatment.  The primary objective was to...

TCT 2024 | PEERLESS: Mechanical Thrombectomy with FlowTriever vs Catheter-Directed Thrombolysis in Intermediate Risk PTE

Pulmonary embolism (PE) continues to be the third cause of cardiovascular mortality. The current clinical guidelines recommend anticoagulation in intermediate risk patients presenting right...

Atherosclerotic Renal Artery Stenosis: To Revascularize or Not

At long term, atherosclerotic renal artery stenosis (RAS) can lead to hypertension, chronic kidney disease, and cardiac failure. Historically, these patients have been referred...

Endovascular Management of Chronic TEPH: Is Coronary Management Extrapolatable in This Scenario?

Chronic thromboembolic pulmonary hypertension (CTEPH) is a condition that causes significant functional limitation. Its surgical treatment, known as pulmonary endarterectomy (PEA), has improved the...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

TCT 2024 | FAVOR III EUROPA

The study FAVOR III EUROPA, a randomized trial, included 2,000 patients with chronic coronary syndrome, or stabilized acute coronary syndrome, and intermediate lesions. 1,008...

TCT 2024 | TRISCEND II

This randomized study included 400 patients; 267 were treated with EVOQUE valve and 133 with optimal medical treatment (OMT). After one-year follow-up, there were no...

TCT 2024 – ACCESS-TAVI: Comparing Percutaneous Access Closure Strategies After TAVI

Vascular access complications following transcatheter aortic valve implantation (TAVI) remain common. However, few studies compare vascular access closure methods.  Based on the CHOICE-CLOSURE and MASH...